Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma

Ravi Vij, Michael Wang, Sundar Jagannath, Ruben Niesvizky, Andrzej J. Jakubowiak, Edward Kavalerchik, Mei Huang, David S. Siegel

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)2959-2961
Number of pages3
JournalLeukemia and Lymphoma
Issue number10
StatePublished - 3 Oct 2015

Cite this